Harris & Harris Group Inc /ny/ (TINY) Files Form 4 Insider Buying : Kevin Rendino Buys 49,493 Shares

Harris & Harris Group Inc /ny/ (TINY): Kevin Rendino , director of Harris & Harris Group Inc /ny/ purchased 49,493 shares on Jun 8, 2016. The Insider buying transaction was reported by the company on Jun 10, 2016 to the Securities and Exchange Commission. The shares were purchased at $1.74 per share for a total value of $85,978.72 , the company said in a SEC Form 4 Filing.

Other Insider transactions have been reported by the company according to SEC Form 4, on Jun 10, 2016, Douglas W Jamison (CEO) purchased 4,000 shares at $1.75 per share price.On May 16, 2016, Stacy Brandom (director) purchased 4,000 shares at $1.70 per share price.Also, On May 16, 2016, Phillip A Bauman (director) purchased 3,280 shares at $1.70 per share price.On May 16, 2016, W Dillaway Jr Ayres (director) purchased 3,800 shares at $1.70 per share price.

Harris & Harris Group (TINY) witnessed a volatile trading activity on Thursday Jun 9, 2016 and eventually ended flat at 0.00% or 0 points without letting the bulls or bears take much advantage. The trading began at $1.73 and reached the intraday high at $1.75. The bulls started the profit booking and pushed the shares to intraday low of $1.72. The trading session was marked by a volume range of 30,511 shares exchanging hands. The 52-week high of the shares is $2.88 and the 52-week low is $1.58. The market cap of the company stands at $54 M and there are 3,08,45,754 shares in public circulation.

Harris & Harris Group Money Flow Index Chart

Harris & Harris Group Inc. is a venture capital firm. The Firm is regulated as a business development company. Its investment objective is to achieve long-term capital appreciation by making venture capital investments. As a venture capital firm it invests in and provides managerial assistance to its portfolio companies. The Firm’s investment has two characteristics: early stage where its focus is on founding incubating and building transformative companies from disruptive science and BIOLOGY+ investments in interdisciplinary life science companies where biology innovation is intersecting with innovations in areas such as electronics physics materials science chemistry information technology engineering and mathematics.

Leave a Reply

Harris & Harris Group - Is it time to Sell?

Top Brokerage Firms are advising their investors on Harris & Harris Group. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.